{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:15:03Z","timestamp":1793481303306,"version":"4.5.0"},"reference-count":27,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>Meningiomas are predominantly benign, but some cases exhibit recurrent growth after surgery and undergo malignant transformation to WHO grade 2 or grade 3. Despite progress in genetic analyses, advancements in metabolomic analysis remain less established. Herein, the authors investigated metabolic activity differences between WHO grade 1 meningiomas and WHO grade 2 or 3 meningiomas by noninvasively using proton magnetic resonance spectroscopy (<jats:sup>1<\/jats:sup>H-MRS), aiming to preoperatively estimate malignancy. They also reviewed the literature to elucidate this aspect of meningioma research.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>At Ryukyu University Hospital, the authors focused on 93 patients diagnosed with meningioma between 2011 and 2021. The inclusion criteria encompassed prior surgery, pathological diagnoses of meningioma, and preoperative <jats:sup>1<\/jats:sup>H-MRS. Group I included 71 patients with WHO grade 1 meningioma and group II included 22 patients, comprising 19 and 3 with WHO grade 2 and 3 meningioma, respectively. The authors retrospectively conducted a comparative analysis of patient backgrounds and tumor metabolites.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>Group I and II did not differ significantly in terms of patient demographic characteristics (age and sex). Group II demonstrated a significantly lower extent of tumor resection (p &lt; 0.01), higher MIB-1 labeling index (LI) (p &lt; 0.05), higher incidence of prior irradiation (p &lt; 0.001), and increased rate of tumor recurrence (p = 0.005) compared to group I. According to <jats:sup>1<\/jats:sup>H-MRS, all metabolites, except lactate, displayed significantly higher median creatine (Cr) ratios in group II than group I: glutamine\/Cr was 8.46, glutamate\/Cr was 9.49, lipid\/Cr was 11.36, and choline\/Cr was 2.77. According to the receiver operating characteristic (ROC) analysis, glutamine had the largest area under the curve of 0.765 among 10 metabolites, and the cutoff value for distinguishing between group I and II was 5.76.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>In cases pathologically graded as WHO grade 2 or 3 meningiomas, metabolic products such as glutamine, glutamate, lipids, and choline increased significantly. These changes were correlated with elevation of the MIB-1 LI. In group II, the mean MIB-1 LI was 8.58, significantly higher than in group I, suggesting a strong association with pathological malignancy. Therefore, <jats:sup>1<\/jats:sup>H-MRS may help to noninvasively predict tumor metabolic activity and tumor recurrence. Furthermore, the authors concluded from the ROC analysis that glutamine may be a potential indicator of future growth of meningioma and benefits of early surgery.<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2024.4.jns24187","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T01:27:51Z","timestamp":1723858071000},"page":"1-10","source":"Crossref","is-referenced-by-count":2,"title":["Metabolic profiling of atypical meningioma and recurrent meningioma: a comparative analysis with proton magnetic resonance spectroscopy"],"prefix":"10.3171","author":[{"given":"Tomomi","family":"Kuninaka","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University of the Ryukyus, Graduate School of Medicine, Nishihara, Okinawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Kisyaba","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of the Ryukyus, Graduate School of Medicine, Nishihara, Okinawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigetaka","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of the Ryukyus, Graduate School of Medicine, Nishihara, Okinawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nagamine","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of the Ryukyus, Graduate School of Medicine, Nishihara, Okinawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Hokama","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of the Ryukyus, Graduate School of Medicine, Nishihara, Okinawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Sugawara","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of the Ryukyus, Graduate School of Medicine, Nishihara, Okinawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of the Ryukyus, Graduate School of Medicine, Nishihara, Okinawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Ishiuchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of the Ryukyus, Graduate School of Medicine, Nishihara, Okinawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"21","key":"b1","series-title":"Future Oncol","first-page":"2161","article-title":"An overview of meningiomas","volume":"14","author":"Buerki RA","year":"2018","unstructured":"Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas RV. An overview of meningiomas. Future Oncol. 2018;14(21):2161\u20132177."},{"issue":"1","key":"b2","series-title":"Neurooncol Adv","first-page":"vdaa129","article-title":"Malignant transformation of WHO grade I meningiomas after surgery or radiosurgery: systematic review and meta-analysis of observational studies","volume":"2","author":"Nakasu S","year":"2020","unstructured":"Nakasu S, Notsu A, Na K, Nakasu Y. Malignant transformation of WHO grade I meningiomas after surgery or radiosurgery: systematic review and meta-analysis of observational studies. Neurooncol Adv. 2020;2(1):vdaa129."},{"issue":"5","key":"b3","series-title":"J Neurosurg","first-page":"1201","article-title":"Correlation between magnetic resonance imaging grading and pathological grading in meningioma","volume":"121","author":"Lin BJ","year":"2014","unstructured":"Lin BJ, Chou KN, Kao HW,  Correlation between magnetic resonance imaging grading and pathological grading in meningioma. J Neurosurg. 2014;121(5):1201\u20131208."},{"issue":"8","key":"b4","series-title":"Neuro Oncol","first-page":"1231","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis DN","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P,  The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231\u20131251."},{"issue":"6","key":"b5","series-title":"Magn Reson Imaging","first-page":"663","article-title":"(1)H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors","volume":"21","author":"Cho YD","year":"2003","unstructured":"Cho YD, Choi GH, Lee SP, Kim JK. (1)H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors. Magn Reson Imaging. 2003;21(6):663\u2013672."},{"key":"b6","series-title":"Neurochem Int","first-page":"29","article-title":"Neuronal vs glial glutamate uptake: resolving the conundrum","volume":"98","author":"Danbolt NC","year":"2016","unstructured":"Danbolt NC, Furness DN, Zhou Y. Neuronal vs glial glutamate uptake: resolving the conundrum. Neurochem Int. 2016;98:29\u201345."},{"issue":"9","key":"b7","series-title":"J Clin Invest","first-page":"3678","article-title":"Glutamine and cancer: cell biology, physiology, and clinical opportunities","volume":"123","author":"Hensley CT","year":"2013","unstructured":"Hensley CT, Wasti AT, DeBerardinis RJ. Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest. 2013;123(9):3678\u20133684."},{"issue":"2","key":"b8","series-title":"Neuroimaging Clin N Am","first-page":"379","article-title":"Proton MR spectroscopy of the brain","volume":"9","author":"Rand SD","year":"1999","unstructured":"Rand SD, Prost R, Li SJ. Proton MR spectroscopy of the brain. Neuroimaging Clin N Am. 1999;9(2):379\u2013395."},{"issue":"4","key":"b9","series-title":"NMR Biomed","first-page":"260","article-title":"Automatic quantitation of localized in vivo 1H spectra with LCModel","volume":"14","author":"Provencher SW","year":"2001","unstructured":"Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001;14(4):260\u2013264."},{"issue":"2","key":"b10","series-title":"NMR Biomed","first-page":"322","article-title":"Classification of single-voxel 1H spectra of brain tumours using LCModel","volume":"25","author":"Raschke F","year":"2012","unstructured":"Raschke F, Fuster-Garcia E, Opstad KS, Howe FA. Classification of single-voxel 1H spectra of brain tumours using LCModel. NMR Biomed. 2012;25(2):322\u2013331."},{"issue":"1","key":"b11","series-title":"Br J Neurosurg","first-page":"77","article-title":"Magnetic resonance imaging characteristics of typical and atypical\/anaplastic meningiomas\u2014case series and literature review","volume":"29","author":"Tan LA","year":"2015","unstructured":"Tan LA, Boco T, Johnson AK,  Magnetic resonance imaging characteristics of typical and atypical\/anaplastic meningiomas\u2014case series and literature review. Br J Neurosurg. 2015;29(1):77\u201381."},{"issue":"4","key":"b12","series-title":"Neuro Oncol","first-page":"556","article-title":"Glutamine anaplerosis is required for amino acid biosynthesis in human meningiomas","volume":"24","author":"Ijare OB","year":"2022","unstructured":"Ijare OB, Hambarde S, Brasil da Costa FH,  Glutamine anaplerosis is required for amino acid biosynthesis in human meningiomas. Neuro Oncol. 2022;24(4):556\u2013568."},{"issue":"22","key":"b13","series-title":"Life Sci","first-page":"1929","article-title":"In vivo 1H MRS choline: correlation with in vitro chemistry\/histology","volume":"58","author":"Miller BL","year":"1996","unstructured":"Miller BL, Chang L, Booth R,  In vivo 1H MRS choline: correlation with in vitro chemistry\/histology. Life Sci. 1996;58(22):1929\u20131935."},{"issue":"4","key":"b14","series-title":"J Neurosurg","first-page":"516","article-title":"Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study","volume":"87","author":"Tedeschi G","year":"1997","unstructured":"Tedeschi G, Lundbom N, Raman R,  Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg. 1997;87(4):516\u2013524."},{"issue":"4","key":"b15","series-title":"J Neurochem","first-page":"1538","article-title":"Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro","volume":"63","author":"Usenius JP","year":"1994","unstructured":"Usenius JP, Vainio P, Hernesniemi J, Kauppinen RA. Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro. J Neurochem. 1994;63(4):1538\u20131543."},{"issue":"11","key":"b16","series-title":"Eur J Nucl Med","first-page":"1664","article-title":"Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging","volume":"28","author":"Ohtani T","year":"2001","unstructured":"Ohtani T, Kurihara H, Ishiuchi S,  Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med. 2001;28(11):1664\u20131670."},{"issue":"6","key":"b17","series-title":"J Lipid Res","first-page":"1187","article-title":"Phosphatidylcholine and choline homeostasis","volume":"49","author":"Li Z","year":"2008","unstructured":"Li Z, Vance DE. Phosphatidylcholine and choline homeostasis. J Lipid Res. 2008;49(6):1187\u20131194."},{"issue":"4","key":"b18","series-title":"Prog Neurobiol","first-page":"245","article-title":"Metabolism and role of glutamate in mammalian brain","volume":"35","author":"Ereci\u0144ska M","year":"1990","unstructured":"Ereci\u0144ska M, Silver IA. Metabolism and role of glutamate in mammalian brain. Prog Neurobiol. 1990;35(4):245\u2013296."},{"issue":"14","key":"b19","series-title":"Future Med Chem","first-page":"1685","article-title":"Therapeutic strategies impacting cancer cell glutamine metabolism","volume":"5","author":"Lukey MJ","year":"2013","unstructured":"Lukey MJ, Wilson KF, Cerione RA. Therapeutic strategies impacting cancer cell glutamine metabolism. Future Med Chem. 2013;5(14):1685\u20131700."},{"issue":"3","key":"b20","series-title":"J Cancer Prev","first-page":"221","article-title":"Oncogenes and tumor suppressors regulate glutamine metabolism in cancer cells","volume":"18","author":"Kim MH","year":"2013","unstructured":"Kim MH, Kim H. Oncogenes and tumor suppressors regulate glutamine metabolism in cancer cells. J Cancer Prev. 2013;18(3):221\u2013226."},{"issue":"9","key":"b21","series-title":"Nat Med","first-page":"971","article-title":"Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells","volume":"8","author":"Ishiuchi S","year":"2002","unstructured":"Ishiuchi S, Tsuzuki K, Yoshida Y,  Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med. 2002;8(9):971\u2013978."},{"issue":"30","key":"b22","series-title":"J Neurosci","first-page":"7987","article-title":"Ca2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation","volume":"27","author":"Ishiuchi S","year":"2007","unstructured":"Ishiuchi S, Yoshida Y, Sugawara K,  Ca2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation. J Neurosci. 2007;27(30):7987\u20138001."},{"issue":"6","key":"b23","series-title":"Neuroradiol J","first-page":"846","article-title":"(1)H MR spectroscopy of meningiomas at 3.0T: the role of glutamate-glutamine complex and glutathione","volume":"24","author":"Crisi G","year":"2011","unstructured":"Crisi G. (1)H MR spectroscopy of meningiomas at 3.0T: the role of glutamate-glutamine complex and glutathione. Neuroradiol J. 2011;24(6):846\u2013853."},{"issue":"7494","key":"b24","series-title":"Nature","first-page":"55","article-title":"Capillary pericytes regulate cerebral blood flow in health and disease","volume":"508","author":"Hall CN","year":"2014","unstructured":"Hall CN, Reynell C, Gesslein B,  Capillary pericytes regulate cerebral blood flow in health and disease. Nature. 2014;508(7494):55\u201360."},{"issue":"3","key":"b25","series-title":"Magn Reson Med","first-page":"294","article-title":"Analysis of macromolecule resonances in 1H NMR spectra of human brain","volume":"32","author":"Behar KL","year":"1994","unstructured":"Behar KL, Rothman DL, Spencer DD, Petroff OA. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med. 1994;32(3):294\u2013302."},{"issue":"6","key":"b26","series-title":"NMR Biomed","first-page":"592","article-title":"MR-visible lipids and the tumor microenvironment","volume":"24","author":"Delikatny EJ","year":"2011","unstructured":"Delikatny EJ, Chawla S, Leung DJ, Poptani H. MR-visible lipids and the tumor microenvironment. NMR Biomed. 2011;24(6):592\u2013611."},{"issue":"1","key":"b27","series-title":"Biochim Biophys Acta","first-page":"47","article-title":"1H NMR-visible mobile lipid domains correlate with cytoplasmic lipid bodies in apoptotic T-lymphoblastoid cells","volume":"1530","author":"Di Vito M","year":"2001","unstructured":"Di Vito M, Lenti L, Knijn A,  1H NMR-visible mobile lipid domains correlate with cytoplasmic lipid bodies in apoptotic T-lymphoblastoid cells. Biochim Biophys Acta. 2001;1530(1):47\u201366."}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/aop\/article-10.3171-2024.4.JNS24187\/article-10.3171-2024.4.JNS24187.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/aop\/article-10.3171-2024.4.JNS24187\/article-10.3171-2024.4.JNS24187.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/aop\/article-10.3171-2024.4.JNS24187\/article-10.3171-2024.4.JNS24187.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T01:25:42Z","timestamp":1735349142000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/aop\/article-10.3171-2024.4.JNS24187\/article-10.3171-2024.4.JNS24187.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":27,"URL":"https:\/\/doi.org\/10.3171\/2024.4.jns24187","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}